Abstract
In 1966, Maroteaux and Lamy first described four girls with pseudo-Hurler polydystrophy, a condition milder in severity than the Hurler syndrome and similar to the Scheie syndrome but without hepatosplenomegaly, cloudy cornea, or mucopolysacchariduria. In 1970, Spranger and Wiedemann (1970) designated pseudo-Hurler polydystrophy as mucolipidosis III because of Hurler-like features and vacuolated bone marrow cells (Kelly et al. 1975a, b).
References
Abualsuod, A., Hacioglu, Y., Vallurupalli, S., et al. (2014). Cardiac MRI findings in mucolipidosis III. Acta Cardiologica, 69, 564–565.
Bargal, R., Zeigler, M., Abu-Libdeh, A., et al. (2006). When mucolipidosis III meets mucolipidosis II: GNPTA gene mutations in 24 patients. Molecular Genetics and Metabolism, 88, 359–363.
Cathey, S., Friez, M., Wood, T., et al. (2007). Exploring mucolipidosis II and III. Molecular Genetics and Metabolism, 90, 240.
Falik-Zaccai, T. C., Zeigler, M., Bargal, R., et al. (2003). Mucolipidosis III type C: First-trimester biochemical and molecular prenatal diagnosis. Prenatal Diagnosis, 23, 211–214.
Freisinger, P., Padovani, J. C., & Maroteaux, P. (1992). An atypical form of mucolipidosis III. Journal of Medical Genetics, 29, 834–836.
Herd, J. K., Dvorak, A. D., Wiltse, H. E., et al. (1978). Mucolipidosis type III. Multiple elevated serum and urine enzyme activities. American Journal of Diseases of Children, 132, 1181–1186.
Hetherington, C., Harris, N. J., & Smith, T. W. (1999). Orthopaedic management in four cases of mucolipidosis type III. Journal of the Royal Society of Medicine, 92, 244–246.
Honey, N. K., Mueller, O. T., Little, L. E., et al. (1982). Mucolipidosis III is genetically heterogeneous. Proceedings of the National Academy of Sciences of the United States of America, 79, 7420–7424.
Kelly, T. E., Thomas, G. H., Taylor, H. A., et al. (1975a). Mucolipidosis III: Clinical and laboratory findings. Birth Defects Original Article Series, 11, 295–299.
Kelly, T. E., Thomas, G. H., Taylor, H. A., Jr., et al. (1975b). Mucolipidosis III (pseudo-Hurler polydystrophy): Clinical and laboratory studies in a series of 12 patients. The Johns Hopkins Medical Journal, 137, 156–175.
Leroy, J. G., Cathey, S., & Friez, M. J. (2012). Mucolipidosis III alpha/beta. GeneReviews. Updated 10 May 2012. Available at http://www.ncbi.nlm.nih.gov/books/NBK1875/
Little, L. E., Mueller, O. T., Honey, N. K., et al. (1986). Heterogeneity of N-acetylglucosamine 1-phosphotransferase within mucolipidosis III. Journal of Biological Chemistry, 261, 733–738.
Liu, S., Zhang, W., Shi, H., et al. (2014). Three novel homozygous mutations in the GNPTG gene that cause mucolipidosis type III gamma. Gene, 535, 294–298.
Maroteaux, P., & Lamy, M. (1966). La pseudo-polydystrophie de Hurler. Presse Médicale, 74, 2889–2892.
Melhem, R., Dorst, J. P., Scott, C. I., Jr., et al. (1973). Roentgen findings in mucolipidosis III (pseudo-Hurler polydystrophy). Radiology, 106, 153–160.
Mueller, O. T., Honey, N. K., Little, L. E., et al. (1983). Mucolipidosis II and III. The genetic relationships between two disorders of lysosomal enzyme biosynthesis. The Journal of Clinical Investigation, 72, 1016–1023.
Raas-Rothschild, A., & Spiegel, R. (2012). Mucolipidosis III gamma. GeneReviews. Updated 5 July 2012. Available at http://www.ncbi.nlm.nih.gov/booksh/NBK24701/
Raas-Rothschild, A., Cormier-Daire, V., Bao, M., et al. (2000). Molecular basis for variant pseudo-Hurler polydystrophy (mucolipidosis IIIC). The Journal of Clinical Investigation, 105, 673–681.
Raas-Rothschild, A., Bargal, R., Goldman, O., et al. (2004). Genomic organization of the UDP-N-acetylglucosamine-1-phosphotransferase gamma subunit (GNPTAG) and its mutations in mucolipidosis III. Journal of Medical Genetics, 41, e52.
Robinow, M. (1974). Mucolipidosis III. Birth Defects Original Article Series, 10, 267–273.
Robinson, C., Baker, N., Noble, J., et al. (2002). The osteodystrophy of mucolipidosis type III and the effects of intravenous pamidronate treatment. Journal of Inherited Metabolic Disease, 25, 681–693.
Smuts, I., Potgieter, D., & van der Westhuizen, F. H. (2009). Combined tarsal and carpal tunnel syndrome in mucolipidosis type III. A case study and review. Annals of the New York Academy of Sciences, 1151, 77–84.
Spranger, J. W., & Wiedemann, H. R. (1970). The genetic mucolipidoses. Diagnosis and differential diagnosis. Humangenetik, 9, 113–139.
Tiede, S., Storch, S., Lubke, T., et al. (2005). Mucolipidosis II is caused by mutations in GNPTA encoding the alpha/beta GlcNAc-1-phosphotransferase. Nature Medicine, 11, 1109–1112.
Traboulsi, E. I., & Maumenee, I. H. (1986). Ophthalmologic findings in mucolipidosis III (pseudo-Hurler polydystrophy). American Journal of Ophthalmology, 102, 592–597.
Tylki-Szymanska, A., Czartoryska, B., Groener, J. E., et al. (2002). Clinical variability in mucolipidosis III (pseudo-Hurler polydystrophy). American Journal of Medical Genetics, 108, 214–218.
Umehara, F., Matsumoto, W., Kuriyama, M., et al. (1997). Mucolipidosis III (pseudo-Hurler polydystrophy); clinical studies in aged patients in one family. Journal of Neurological Sciences, 146, 167–172.
Van Meel, E., & Kornfeld, S. (2016). Mucolipidosis III GNPTG missense mutations cause misfolding of the γ Subunit of GlcNAc-1-phosphotransferase. Human Mutation, 37, 623–626.
Zarza, L. P., & Morrondo, C. D. (2014). Skeletal deformities in mucolipidosis III. Rheumatology Clinic, 10, 340–341.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this entry
Cite this entry
Chen, H. (2016). Mucolipidosis 3. In: Atlas of Genetic Diagnosis and Counseling. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6430-3_167-2
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6430-3_167-2
Received:
Accepted:
Published:
Publisher Name: Springer, New York, NY
Online ISBN: 978-1-4614-6430-3
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences